Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
影响地诺单抗24个月持续治疗率的因素：一项针对德国、奥地利、希腊和比利时绝经后骨质疏松症女性的真实世界非干预性研究结果
期刊:Archives of Osteoporosis
影响因子:2.8
doi:10.1007/s11657-017-0351-2
Fahrleitner-Pammer, A; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Toffis, C; Frieling, I; Geusens, P; Makras, P; Boschitsch, E; Callens, J; Anastasilakis, A D; Niedhart, C; Resch, H; Kalouche-Khalil, L; Hadji, P
